MCID: FLL031
MIFTS: 35

Follicular Adenoma malady

Categories: Cancer diseases, Endocrine diseases

Aliases & Classifications for Follicular Adenoma

About this section

Aliases & Descriptions for Follicular Adenoma:

Name: Follicular Adenoma 10 12 65
Follicular Adenoma of the Thyroid Gland 10
Thyroid Gland Follicular Adenoma 65
 
Thyroid Follicular Adenoma 10
Adenoma Follicular 47

Classifications:



External Ids:

Disease Ontology10 DOID:6204
SNOMED-CT59 55021007
MeSH36 D000236
UMLS65 C0205647, C0151468

Summaries for Follicular Adenoma

About this section
MalaCards based summary: Follicular Adenoma, also known as follicular adenoma of the thyroid gland, is related to thyroiditis and atypical follicular adenoma. An important gene associated with Follicular Adenoma is LGALS3 (Lectin, Galactoside Binding Soluble 3), and among its related pathways are Thyroid cancer and Thyroxine (Thyroid Hormone) Production. Affiliated tissues include thyroid, bone and liver, and related mouse phenotypes are pigmentation and limbs/digits/tail.

Related Diseases for Follicular Adenoma

About this section

Diseases related to Follicular Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 147)
idRelated DiseaseScoreTop Affiliating Genes
1thyroiditis29.9TG, TPO, TSHR
2atypical follicular adenoma12.5
3oxyphilic adenoma11.4
4autoimmune thyroiditis10.5TG, TPO
5thyroid ectopia10.5TG, TPO
6neonatal meningitis10.5TG, TPO
7rhabdomyosarcoma, embryonal, 210.5TG, TPO
8solar retinopathy10.4TG, TPO
9setariasis10.4TG, TPO
10hypothryoidism, congenital, nongoitrous 410.4TG, TPO
11megaloblastic anemia10.3TG, TPO
12primary gastrointestinal melanoma10.3CDKN1B, PTEN
13goiter10.3SLC26A4, TG
14glaucoma, primary open angle, juvenile-onset, 210.2TG, TPO
15spastic ataxia 210.2CDKN1B, PAX8
16gastroesophageal junction adenocarcinoma10.2MCM2, PAX8
17laryngeal mucoepidermoid carcinoma10.1CALCA, TG
18skin angiosarcoma10.1CALCA, TG
19hypertelorism, preauricular sinus, punctal pits, and deafness10.1TG, TPO, TSHR
20accommodative spasm10.1TG, TPO, TSHR
21artemis deficiency10.1TG, TPO, TSHR
22ischemia10.1
23posterior uveitis10.1PAX8, TSHR
24scabies10.1CALCA, TG
25mediastinum teratoma10.1NKX2-1, RET, TG
26corneal ectasia10.1CALCA, TG
27fuchs' heterochromic uveitis10.1TG, TSHR
28frontal convexity meningioma10.1TG, TPO, TSHR
29chest wall lymphoma10.1CALCA, TG
30benign struma ovarii10.1KRT19, LGALS3, RET, TG
31rh isoimmunization10.0TG, TPO, TSHR
32thyrotoxic exophthalmos10.0TG, TPO, TSHR
33brachyolmia10.0KRT19, NKX2-1, PTEN
34hypoaldosteronism10.0CALCA, TG
35chronic inflammatory demyelinating polyradiculoneuropathy10.0RET, TG, TSHR
36asthma10.0
37hepatitis10.0
38leukemia10.0
39diverticulitis10.0
40anoxia10.0
41non-invasive bladder papillary urothelial neoplasm10.0NKX2-1, TG
42bone cancer10.0CALCA, TG, TPO
43ovarian endometrioid cystadenoma10.0CALCA, TG, TPO
44central hypoventilation syndrome, congenital9.9CALCA, RET
45deafness, autosomal recessive 4, with enlarged vestibular aqueduct9.9PAX8, SLC26A4, TG, TPO
46ulcerative blepharitis9.9CALCA, TPO
47schizophrenia9.8
48prostate cancer9.8
49breast cancer9.8
50bacteremia9.8

Graphical network of the top 20 diseases related to Follicular Adenoma:



Diseases related to follicular adenoma

Symptoms for Follicular Adenoma

About this section

Drugs & Therapeutics for Follicular Adenoma

About this section

Drugs for Follicular Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 2158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
CisplatinapprovedPhase 2254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
3
TamoxifenapprovedPhase 235010540-29-12733526
Synonyms:
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)
(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
,citrate
1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
10540-29-1
1ya4
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
54965-24-1 (citrate)
AC1MBZ3R
Apo-Tamox
Apo-tamox
BIDD:ER0008
BIDD:GT0009
BIDD:PXR0003
BPBio1_000278
BRD-K93754473-001-02-9
BRD-K93754473-048-05-3
BSPBio_000252
BSPBio_001150
BSPBio_001982
C07108
C26H29NO
CCRIS 3275
CHEBI:41774
CHEMBL83
CID2733526
Citofen
Crisafeno
D08559
DB00675
Diemon
EINECS 234-118-0
Gen-Tamoxifen
Gen-tamoxifen
HMS1362J11
HMS1792J11
HMS1990J11
HMS2090N08
HSDB 6782
ICI 47699
ICI-46,474
ICI-47699
IDI1_000258
IDI1_002170
Istubol
Kessar
L024126
LS-393
Lopac0_001203
MLS001332535
MLS001332536
MolPort-003-850-384
 
NCGC00024928-01
NCGC00024928-03
NCGC00024928-04
NCGC00024928-05
NCGC00024928-07
NCGC00024928-08
NCGC00024928-09
NCGC00024928-12
NSC727681
Noltam
Nolvadex
Nolvadex-D
Nourytam
Novaldex
Novo-Tamoxifen
Oncomox
PMS-Tamoxifen
Pms-Tamoxifen
Prestwick2_000146
Prestwick3_000146
QTL1_000079
Retaxim
SMR000059172
ST50511785
Soltamox
Spectrum5_001417
Spectrum5_002043
T5648_SIGMA
TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))
TRANS FORM OF TAMOXIFEN
Tamizam
Tamofen
Tamone
Tamoplex (TN)
Tamoxasta
Tamoxen
Tamoxifen
Tamoxifen (INN)
Tamoxifen (TN)
Tamoxifen (Z)
Tamoxifen Citrate
Tamoxifen [INN:BAN]
Tamoxifen and its salts
Tamoxifene
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tamoxifène
Tocris-0999
Tomaxithen
Trans-Tamoxifen
UNII-094ZI81Y45
UPCMLD-DP027
Valodex
Zemide
cMAP_000044
nchembio.140-comp7
nchembio.76-comp1
nchembio732-comp3
tamoxifen
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
trans-Tamoxifen
4
DoxilApproved June 1999Phase 2158231703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
5Hormone AntagonistsPhase 210002
6HormonesPhase 211748
7Liver ExtractsPhase 23572
8Topoisomerase InhibitorsPhase 24081
9Anti-Bacterial AgentsPhase 29140
10EstrogensPhase 22144
11Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 29988
12Selective Estrogen Receptor ModulatorsPhase 2501
13Antineoplastic Agents, HormonalPhase 24256
14Estrogen Receptor ModulatorsPhase 2544
15Bone Density Conservation AgentsPhase 22600
16Antibiotics, AntitubercularPhase 25971
17Estrogen AntagonistsPhase 21155
18
Citric AcidnutraceuticalPhase 2100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
19CitrateNutraceuticalPhase 21001
20
PaclitaxelapprovedPhase 1262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
21
Trastuzumabapproved, investigationalPhase 1726180288-69-19903
Synonyms:
180288-69-1
Anti HER2
Anti-erbB2 Monoclonal Antibody
D03257
HER2 Monoclonal Antibody
Herceptin
 
Herceptin (TN)
Ig gamma-1 chain C region
Trastuzumab
Trastuzumab (INN)
Trastuzumab (genetical recombination)
Trastuzumab (genetical recombination) (JAN)
trastuzumab
22
CarboplatinapprovedPhase 1188541575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
23Immunologic FactorsPhase 118483
24Interleukin-12Phase 1125
25Tubulin ModulatorsPhase 14279
26Angiogenesis Modulating AgentsPhase 13611
27Adjuvants, ImmunologicPhase 11783
28Antineoplastic Agents, PhytogenicPhase 14294
29Albumin-Bound PaclitaxelPhase 12621
30Angiogenesis InhibitorsPhase 13688
31Antimitotic AgentsPhase 14296
32
Iodine4947553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
33cadexomer iodine456

Interventional clinical trials:

idNameStatusNCT IDPhase
1Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
2Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph AdenomasTerminatedNCT00929669Phase 2
3Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
4Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmCompletedNCT01433809
5Molecular Markers in Thyroid CancerCompletedNCT00598364
6Expression of NIS Protein and mRNA in Thyroid TumorsCompletedNCT00459498
7ctDNA in Patients With Thyroid NodulesRecruitingNCT02778412
8Evaluation of a New CZT SystemNot yet recruitingNCT01084356

Search NIH Clinical Center for Follicular Adenoma

Genetic Tests for Follicular Adenoma

About this section

Anatomical Context for Follicular Adenoma

About this section

MalaCards organs/tissues related to Follicular Adenoma:

33
Thyroid, Bone, Liver, Prostate, Breast, Brain, Skin

Animal Models for Follicular Adenoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Follicular Adenoma:

38 (show all 17)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.1CDKN1B, MCM2, PTEN, SLC26A4
2MP:00053719.0PAX8, PTEN, RET, TPO, TSHR
3MP:00053888.5CDKN1B, LGALS3, MCM2, NKX2-1, PTEN, RET
4MP:00053678.3CDKN1B, LGALS3, PAX8, PTEN, RET, SLC26A4
5MP:00020068.2CDKN1B, KRT19, LGALS3, MCM2, NKX2-1, PTEN
6MP:00053778.1CDKN1B, PAX8, SLC26A4, TPO, TSHR
7MP:00053818.1CDKN1B, KRT19, LGALS3, MCM2, NKX2-1, PTEN
8MP:00053867.5CDKN1B, LGALS3, MCM2, NKX2-1, PTEN, RET
9MP:00053907.3KRT19, LGALS3, NKX2-1, PAX8, PTEN, SLC26A4
10MP:00053977.3CDKN1B, LGALS3, MCM2, PTEN, RET, TG
11MP:00053897.0CDKN1B, KRT19, LGALS3, NKX2-1, PAX8, PTEN
12MP:00107686.7CDKN1B, KRT19, LGALS3, MCM2, NKX2-1, PAX8
13MP:00053766.5CDKN1B, DPP4, LGALS3, NKX2-1, PAX8, PTEN
14MP:00036316.4CDKN1B, KRT19, LGALS3, MCM2, NKX2-1, PAX8
15MP:00053786.4CDKN1B, DPP4, KRT19, MCM2, NKX2-1, PAX8
16MP:00053796.2CDKN1B, DPP4, KRT19, MCM2, NKX2-1, PAX8

Publications for Follicular Adenoma

About this section

Articles related to Follicular Adenoma:

(show top 50)    (show all 108)
idTitleAuthorsYear
1
Tobacco-Related Mortality among Persons with Mental Health and Substance Abuse Problems. (25807109)
2015
2
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report. (25886790)
2015
3
DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERI+-positive breast cancer cells. (25663546)
2015
4
Acute myocardial infarction caused by a floating thrombus in the proximal ascending aorta. (26552469)
2015
5
Bone Cement-Augmented Percutaneous Short Segment Fixation: An Effective Treatment for Kummell's Disease? (26279814)
2015
6
The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. (26468327)
2015
7
The effect of constant darkness and circadian resynchronization on the recovery of alcohol hangover. (24717330)
2014
8
The V86M mutation in HIV-1 capsid confers resistance to TRIM5I+ by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import. (23448277)
2013
9
Efficacy of interventions to improve motor performance in children with developmental coordination disorder: a combined systematic review and meta-analysis. (23106530)
2013
10
Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway. (23525475)
2013
11
360A^ fusion for Charcot spine caused by congenital insensitivity to pain with anhidrosis. (24157171)
2013
12
Mifepristone (Korlym) for Cushing's syndrome. (22683927)
2012
13
Unsulfated cholecystokinin: An overlooked hormone? (21985915)
2012
14
Testosterone and interleukin-1I^ increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. (22328081)
2012
15
Effect of polymorphisms of IL-1I^ and TNF-I+ genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa. (21400614)
2011
16
Akt phosphorylates and regulates the osteogenic activity of Osterix. (21777568)
2011
17
Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFI^1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand. (21541994)
2011
18
Targeting plasma membrane GRP78 for cancer growth inhibition. (20026905)
2010
19
King George III and porphyria: a clinical re-examination of the historical evidence. (21877427)
2010
20
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. (19887503)
2010
21
Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. (19214165)
2009
22
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. (19864232)
2009
23
Serum ghrelin levels in children with primary protein-energy malnutrition. (18937750)
2008
24
Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. (17934892)
2008
25
Visual restoration in cortical blindness: insights from natural and TMS-induced blindsight. (16864478)
2006
26
Current concepts and controversies in the treatment of alcoholic hepatitis. (17109510)
2006
27
DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. (16434481)
2006
28
Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma. (16740031)
2006
29
Femoral neuropathy following retroperitoneal hemorrhage: case series and review of the literature. (16741653)
2006
30
Hypercalcemia in prostate cancer with positive neuron-specific enolase stain. (15354984)
2004
31
The ratio of 2nd to 4th digit length: a proxy for transactivation activity of the androgen receptor gene? (12208164)
2002
32
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients. (12404169)
2002
33
Cloning and characterization of a human beta,beta-carotene-15,15- prime dioxygenase that is highly expressed in the retinal pigment epithelium. (11401432)
2001
34
Induction of ovulation by clomiphene citrate in the Indian vespertilionid bat, Scotophilus heathi. (10861555)
2000
35
Generation of transmembrane electrical potential during NADH oxidation via the external pathway and the fatty acid uncoupling effect after transient opening of the Ca2+-dependent cyclosporin A-sensitive pore in liver mitochondria. (10810187)
2000
36
Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. (10744039)
2000
37
Bile duct adenocarcinoma mimicking veno-occlusive disease after autologous bone marrow transplantation for acute leukaemia. (9674864)
1998
38
Tyrosine phosphorylation of a 94-kDa protein associated with GRB2/ASH is implicated in the signal transduction of hematopoietic survival factors. (8670205)
1996
39
Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production. (7538426)
1995
40
Effects on plasma lipoproteins and endogenous sex hormones of substituting lean white fish for other animal-protein sources in diets of postmenopausal women. (1550074)
1992
41
Osteocalcin in patients with rheumatoid arthritis--effect of anatomical stages, inflammatory activity and therapy. (1290023)
1992
42
Voltage-gated sodium channels expressed in the human cerebellar medulloblastoma cell line TE671. (2160039)
1990
43
An autopsy case of disseminated trichosporonosis with candidiasis of the urinary bladder. (2512744)
1989
44
Cystic ovarian enlargement resulting from autoimmune oophoritis. (2761940)
1989
45
Glomus tumor of the stomach. (6322071)
1984
46
Evidence for an apparent sensory speech disorder in Parkinson's disease. (6470725)
1984
47
Influence of medium-chain triglycerides on steatorrhea--in maldigestion, malabsorption and primary exudative enteropathy. (5101522)
1971
48
A case of rhinoscleroma. (14872785)
1951
49
50

Variations for Follicular Adenoma

About this section

Expression for genes affiliated with Follicular Adenoma

About this section
Search GEO for disease gene expression data for Follicular Adenoma.

Pathways for genes affiliated with Follicular Adenoma

About this section

Pathways related to Follicular Adenoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8PAX8, RET
29.4TG, TPO, TSHR
39.1CDKN1B, NKX2-1, PAX8
48.8CDKN1B, PAX8, PTEN, RET
5
Show member pathways
8.1NKX2-1, PAX8, SLC26A4, TG, TPO, TSHR

GO Terms for genes affiliated with Follicular Adenoma

About this section

Biological processes related to Follicular Adenoma according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1hormone biosynthetic processGO:004244610.1TG, TPO
2thyroid hormone generationGO:000659010.0TG, TPO
3thyroid gland developmentGO:00308789.9NKX2-1, TG
4iodide transportGO:00157059.9SLC26A4, TG
5negative regulation of epithelial cell proliferationGO:00506809.5CDKN1B, PTEN
6locomotory behaviorGO:00076269.5NKX2-1, PTEN
7feeding behaviorGO:00076319.2CALCA, NKX2-1
8activation of adenylate cyclase activityGO:00071908.8CALCA, TSHR

Sources for Follicular Adenoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet